I quite agree, and I might add that the retailers have now been cornered into a position where the ONLY relevant news that the company can announce is related to meaningful revenue. Not promises or future studies or anything like that. It's ceased to be about anything but the money, nothing else. It could have been much more positive but the BoD have blown their own cover and shown that ethics has little to do with this company.
Ann: NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs, page-71
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.0¢ | $15.63K | 71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20907 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 30000 | 2 |
View Market Depth
| Last trade - 11.55am 11/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |